SCHEDULE: Meitav Investment House Discloses 5.24% Stake in Brainsway

Meitav Investment House Ltd. has filed a Schedule 13G reporting a 5.24% beneficial ownership stake in Brainsway Ltd. as of March 31, 2026.

Summary

• Meitav Investment House Ltd. reported beneficial ownership of 2,099,637 ordinary shares of Brainsway Ltd.
• The reported stake represents 5.24% of the total 40,033,028 ordinary shares outstanding.
• The holdings are distributed between Meitav Tachlit Mutual Funds Ltd. (1.02%) and Meitav Provident Funds & Pension Ltd. (4.22%).
• The filing clarifies that the reporting person and its subsidiaries disclaim beneficial ownership in excess of their actual pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory event, representing standard institutional portfolio activity rather than a fundamental change in company outlook.

Positives

• Institutional investor confidence indicated by a significant 5.24% equity position.
• The filing confirms the investment is held for passive purposes, not intended to influence or change control of the issuer.

Negatives

• None identified; this is a standard regulatory disclosure of institutional holdings.

Risks

• Market volatility affecting the value of the underlying American Depositary Shares.
• Potential for future divestment by the reporting entity which could impact share price liquidity.

Future Outlook

The reporting person states the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Management Comments

• The reporting person certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that institutional 13G filings are standard disclosures for asset managers and do not typically signal strategic shifts, but rather reflect portfolio rebalancing or long-term investment strategies within the medical technology sector.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for institutional investors exceeding the 5% ownership threshold.
• The disclosure structure is consistent with typical filings by Israeli-based investment houses holding US-listed securities.

Stakeholder Impact

• Shareholders may view the 5.24% institutional stake as a sign of stability and long-term interest in the company.

Next Steps

• No specific future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Brainsway, Meitav Investment House, Schedule 13G, Institutional Ownership, BWAY, Beneficial Ownership